ABCL Abcellera Biologics Inc
P/E
--
Forward P/E
27.55
Price/Sales
59.94
Beta
1.41
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Abcellera Pops 7.8% Ahead of Jefferies Conference — But Can a Slide Deck Justify a $1.8 Billion Valuation for a Company That Made $8 Million Last Quarter?
Shares of AbCellera Biologics jumped 7.8% to $6.17 on June 4, rebounding sharply from two straight losing sessions as traders bet the company's presentation at...
🟢 Abcellera Biologics Inc is trading 7.9% up today ahead of Jefferies Global Healthcare Conference presentation
Abcellera Biologics Inc is trading 7.9% up at $6.17 as investors position themselves ahead of the company's scheduled appearance at the Jefferies Global...
🟢 Abcellera Biologics Inc. is trading 3.67% up ahead of its presentation at the Jefferies Global Healthcare Conference
Abcellera Biologics Inc. is trading at $5.93, a gain of 3.67% today, as investors look ahead to the company's presentation at a major investor conference. •...